SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments

Overview of attention for article published in Frontiers in Neurology, February 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 3 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 27,596 followers.

SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments https://t.co/mrwhCr6YDQ

16 Mar 2023

Reply Repost Favourite

SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments https://t.co/PQhpBrDNfk https://t.co/yxZWmQvdv7

25 Feb 2023

Reply Repost Favourite

RT @FrontNeurol: New Research: SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis…

24 Feb 2023

Reply Repost Favourite

New Research: SARS-CoV-2-specific antibody responses following BNT162b2 vaccination in individuals with multiple sclerosis receiving different disease-modifying treatments: Introduction The study aims to evaluate the concentration of IgG… https://t.co/iPn

24 Feb 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.